NEWS RELEASE for September 17, 2003 at 7:35 AM EDT
Contact: Allen & Caron CLOSURE Medical Corp
Joe Allen (investors) Len Hall (media) Benny Ward, CFO
212-691-8087 949-474-4300 919-876-7800
CLOSURE MEDICAL CORPORATION TO PRESENT AT THE UBS WARBURG
GLOBAL LIFE SCIENCES CONFERENCE
RALEIGH, NC (September 17, 2003) … CLOSURE Medical Corporation (Nasdaq: CLSR), a global leader in medical adhesives, is scheduled to present at the UBS Warburg Global Life Sciences Conference at The Plaza Hotel in New York City. Daniel A. Pelak, President and Chief Executive Officer, will deliver the Company's presentation on Wednesday, September 24, 2003, beginning at 12:00 p.m. EDT. A live webcast of the presentation will be available at www.closuremed.com or www.ibb.ubs.com.
CLOSURE Medical Corporation is a global leader in the development, manufacture, and commercialization of medical adhesives based on its proprietary medical grade cyanoacrylate technology. CLOSURE’s proprietary technology has customized the physical and chemical properties of cyanoacrylates to develop medical adhesive formulations to close and seal topical skin wounds and incisions.